IHS Bioceuticals

IHS Bioceuticals, LLC was a Florida-based biotechnology and consumer health company that specialized in natural treatments for joint pain and inflammation. The company's primary product line, marketed under the brand name Celecaine (also spelled Cellecaine), featured topical creams and oral capsules formulated with a proprietary blend of cetylated fatty acids. These products were supported by clinical research, including studies published in The Journal of Rheumatology, which demonstrated their efficacy in improving range of motion and physical function in patients with osteoarthritis. IHS Bioceuticals primarily targeted the chiropractic and physical therapy markets before becoming inactive in the early 2010s.